Latest Sales Expansion News

Hallenstein Glasson delivered a sharp lift in FY2026 profit as sales, margins and Australian trading strengthened. The NZX-listed retailer also raised its full-year dividend to 69 cents per share, while warning that early FY2027 sales growth is unlikely to persist at the same pace.

Boresight Ltd (ASX: BST) recorded a 46% increase in revenue to $6.38 million for FY26, driven by global sales expansion and strategic investments including an $8 million IPO. Despite this growth, the company posted a $6.66 million net loss, largely due to increased operational expenses and significant share-based payments.

Wiseway Group delivered 10.1% revenue growth to $205.6 million in FY26, led by a 22.2% surge in its eCommerce Solutions division, while maintaining EBITDA margins amid cost discipline. The Group declared a fully franked final dividend of 0.6 cents per share.

Flight Centre Travel Group posted record total transaction value (TTV) of $25.7 billion in FY26, with statutory profit after tax surging 38% despite a $60 million Q4 leisure profit hit from Middle East tensions. The company declared a fully franked 30c dividend and launched a new $200 million buy-back program.

Memphasys secures exclusive Felix™ commercialisation agreement in Poland, marking its third European market entry with a two-year contract valued at approximately A$350,000.

Murray Cod Australia (ASX:MCA) reported a 53% jump in FY26 sales volumes and a 17.9% rise in customer receipts, underpinned by new retail deals with Coles and Woolworths and a focused cost-cutting program.

Spectur Limited posted its strongest quarter of cash receipts in FY26, driven by new contracts and a major technology upgrade, while launching legal action over significant customer losses.

Clever Culture Systems has doubled its large pharmaceutical customer base to eight, installed 34 APAS Independence instruments, and expects FY27 sales growth driven by existing and new customers. The company maintains a $1.7 million cash balance, raised $1.6 million in short-term debt, and is expanding validation services.

PainChek lifted implemented ARR by 5.9% to $4.46 million and secured its first US commercial contracts under a major Sabra REIT agreement, boosting customer receipts 27% in the June quarter.

Imricor Medical Systems has officially launched its US commercial operations, securing Rady Children’s Hospital–San Diego as the first customer for its NorthStar iMR mapping system, following key FDA clearances including pediatric approvals.

Activeport has raised $3.6 million through an oversubscribed placement led by top-tier investors including Antipodes Partners and Scobie Ward, bolstering its balance sheet to accelerate growth in network automation software.

PolyNovo has delivered solid FY26 revenue growth of 16.1%, driven by commercial sales expansion and improved manufacturing output, while progressing insurance recovery from its R&D centre fire.